ALPA HEAL Share Price Nasdaq

ALPAU

US02073F2039

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-2.60%	-2.60%

2023	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Alpha Healthcare Acquisition Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company intend to focus on the healthcare industry. The Company has not conducted any operations and has not generated any revenues.

Sector

More about the company

Income Statement Evolution

More financial data

Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Alpha Healthcare Acquisition Corp. III(NasdaqCM:ALPA) dropped from NASDAQ Composite Index	17/23/17	CI
Alpha Healthcare Acquisition Completes Combination With Carmell Therapeutics	15/23/15	MT
Carmell Therapeutics Corporation completed the acquisition of Alpha Healthcare Acquisition Corp. III from a group of shareholders in a reverse merger transaction.	14/23/14	CI
Alpha Healthcare Acquisition Executes Non-Binding Letter of Intent to Acquire Regenerative Medicine Company	27/23/27	MT
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Alpha Healthcare Acquisition Corp. III Auditor Raises 'Going Concern' Doubt	17/23/17	CI
Alpha Healthcare Acquisition Corp. III to Merge With Carmell Therapeutics	05/23/05	MT
Alpha Healthcare Acquisition Corp. III executed a definitive business combination agreement to acquire Alpha Healthcare Acquisition Corp. III from a group of shareholders for approximately $150 million in a reverse merger transaction.	04/23/04	CI
Alpha Healthcare Acquisition Corp. III executed a definitive business combination agreement to acquire Carmell Therapeutics Corporation for approximately $150 million.	04/23/04	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary	21/03	AQ
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field	19/03	AQ
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	26/02	AQ
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors	16/11	AQ
ALPA HEAL : Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - Form 8-K	16/11	PU

ALPA HEAL Share Price Nasdaq

Equities

ALPAU

US02073F2039

Chart ALPA HEAL

Latest news about ALPA HEAL

Press releases ALPA HEAL

Company Profile

Income Statement Evolution